Maddie's Fund donates $1.7 million to Cornell
ALAMEDA, CALIF. - 10/20/05 - Maddie's Fund awarded Cornell University a six-year, $1.7 million grant to develop a shelter medicine program.
ALAMEDA, CALIF. - 10/20/05 - Maddie's Fund awarded Cornell University a six-year, $1.7 million grant to develop a shelter medicine program.
The goal of the program is to educate veterinarians and students in the field of animal shelter medicine and to promote animal adoptions with a "no kill" philosophy.
The shelter program consists of residency training, veterinary student training, diagnostic and consultative support for shelters and shelter medicine research.
The program will establish a three-year residency. Residents will complete training for a Masters of Science in Epidemiology while becoming certified by the College of Veterinary Medicine at Cornell.
Two elective courses will be available to students - Issues and Preventative Medicine in Animal Shelters and Managing Infectious Disease in Small Animal Populations.
The program will be named Maddie's Shelter Medicine Program in honor of the Miniature Schnauzer that inspired the donors.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
Podcast CE: A Surgeon’s Perspective on Current Trends for the Management of Osteoarthritis, Part 1
May 17th 2024David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to discuss a proactive approach to the diagnosis of osteoarthritis and the best tools for general practice.
Listen
dvm360 announces winners of the Veterinary Heroes program
Published: September 6th 2024 | Updated: November 5th 2024This year’s event is supported by corporate sponsor Schwarzman Animal Medical Center and category sponsors Blue Buffalo Natural, MedVet, Banfield Pet Hospital, Thrive Pet Healthcare and PRN Pharmacal.
Read More
